Dr. Elizabeth “Betsy” Dovec

Dr. Betsy Dovec leads BodybyBariatrics, where she implements comprehensive medical protocols for obesity treatment and weight management. Her clinical focus centers on GLP-1 agonist medications, including Ozempic, Wegovy, and Mounjaro, with structured evaluation processes preceding any prescription. The practice integrates pharmaceutical interventions with behavioral health support and nutritional counseling to address multiple factors affecting weight regulation. Her medical approach combines pharmacological treatment, lifestyle modification strategies, and intensive patient education programs. NPR and Authority Magazine have featured her analysis of weight loss medication protocols and prescribing standards. She regularly addresses clinical communities on patient screening methods, medication safety profiles, and evidence-based treatment selection. BodybyBariatrics maintains specific protocols for pre-treatment screening, ongoing monitoring, and outcome assessment. The practice documents patient responses to GLP-1 agonists while tracking adherence to complementary lifestyle changes. Dr. Dovec contributes to professional discourse on ethical prescribing practices and appropriate patient selection criteria for weight management medications.